ZA952771B - Novel compound - Google Patents

Novel compound

Info

Publication number
ZA952771B
ZA952771B ZA952771A ZA952771A ZA952771B ZA 952771 B ZA952771 B ZA 952771B ZA 952771 A ZA952771 A ZA 952771A ZA 952771 A ZA952771 A ZA 952771A ZA 952771 B ZA952771 B ZA 952771B
Authority
ZA
South Africa
Prior art keywords
isoestrone
hydroxyestra
tetraen
dehydro
alpha
Prior art date
Application number
ZA952771A
Other languages
English (en)
Inventor
Frederick Quincy Gemmill Jr
Chester Eugene Orzech
Steven Jay Adelman
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of ZA952771B publication Critical patent/ZA952771B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA952771A 1994-04-08 1995-04-04 Novel compound ZA952771B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/224,849 US5395831A (en) 1994-04-08 1994-04-08 Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone

Publications (1)

Publication Number Publication Date
ZA952771B true ZA952771B (en) 1996-10-04

Family

ID=22842497

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA952771A ZA952771B (en) 1994-04-08 1995-04-04 Novel compound

Country Status (18)

Country Link
US (3) US5395831A (fr)
EP (1) EP0754190B1 (fr)
JP (1) JPH09511748A (fr)
KR (1) KR970702291A (fr)
CN (1) CN1149298A (fr)
AT (1) ATE177111T1 (fr)
AU (1) AU688029B2 (fr)
CA (1) CA2186486A1 (fr)
DE (1) DE69508068T2 (fr)
DK (1) DK0754190T3 (fr)
ES (1) ES2128051T3 (fr)
GR (1) GR3030185T3 (fr)
HU (1) HUT76338A (fr)
IL (1) IL113178A (fr)
NZ (1) NZ283951A (fr)
TW (1) TW314468B (fr)
WO (1) WO1995027724A1 (fr)
ZA (1) ZA952771B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395831A (en) * 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone
WO1997008187A1 (fr) * 1995-08-30 1997-03-06 Eli Lilly And Company Esters n-butylsulfonate d'oestrogenes
US5998639A (en) * 1995-11-06 1999-12-07 Akzo Nobel, N.V. Sulfatation of estrogen mixtures
ZA968873B (en) * 1995-11-06 1997-05-28 Akzo Nobel Nv Isomerisation of equillin
AU703814B2 (en) * 1995-12-04 1999-04-01 Wyeth Antioxidant
ID18256A (id) * 1996-09-16 1998-03-19 American Home Prod Penggunaan dari 8,9-dehidro estron sebagai estrogen dengan hasil netral pada tingkat prolaktin
IL124213A (en) * 1997-05-02 2004-12-15 Akzo Nobel Nv Sulfation of estrogen mixtures
DE19723794A1 (de) * 1997-06-06 1998-12-10 Jenapharm Gmbh Nichtestrogene Derivate des Estradiols mit antioxidativer Aktivität
US5866561A (en) * 1997-08-21 1999-02-02 Scimed Life Systems, Inc. Local delivery of estrogen for angiogenesis
GB9817623D0 (en) 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
WO2002036605A2 (fr) * 2000-11-03 2002-05-10 Washington University Structures de cycles aromatiques modifies a substitution hydroxy et a activite cytoprotectrice
AU2002228891A1 (en) * 2000-11-17 2002-05-27 Washington University Cytoprotective estrogen derivatives
US20030158432A1 (en) * 2002-01-08 2003-08-21 Leonard Thomas W. Synthesis of a mixture of sulfated estrogens using a sulfur trioxide complex
US6855735B2 (en) 2002-03-20 2005-02-15 Temple University Of The Commonwealth System Of Higher Education Ketamine treatment of restless legs syndrome
PT1490392E (pt) * 2002-04-01 2007-04-30 Univ Florida Quinóis esteroidais como pró-fármacos de antioxidantes
US20070213310A1 (en) * 2002-04-01 2007-09-13 Laszlo Prokai Prodrugs for Use as Ophthalmic Agents
US7186707B2 (en) 2002-04-01 2007-03-06 University Of Florida Prodrugs for use as ophthalmic agents
US7300926B2 (en) * 2002-04-01 2007-11-27 University Of Florida Research Foundation, Inc. Steroidal quinols and their use for estrogen replacement therapy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE205169C (fr) *
US3394153A (en) * 1965-08-18 1968-07-23 Merck & Co Inc Process for the preparation of d, 1-8-dehydroestrone, and intermediates obtained therefrom
US3391170A (en) * 1965-09-21 1968-07-02 Smith 13-alkylogona-1, 3, 5 (10), 9 (11)-tetraenes
US3385872A (en) * 1966-08-29 1968-05-28 Syntex Corp Process for the preparation of 3-hydroxy-19-nor-delta1, 3, 5(10), 9(11)-tetraene steroids
US3471528A (en) * 1968-02-21 1969-10-07 Lilly Co Eli Method for producing delta**9(11) unsaturation in estrone and related compound
US3542819A (en) * 1968-06-11 1970-11-24 American Home Prod Process for preparing 8-isoestrone
US3649621A (en) * 1969-12-19 1972-03-14 American Home Prod Novel 3-cyclopentyl ethers of 13-alkylgon-poly-enes
US3689512A (en) * 1970-10-06 1972-09-05 American Home Prod Novel 3-etherified-1,3,5(10)-triene-steroids and process thereof
DE3014120A1 (de) * 1980-04-12 1981-10-29 Hoechst Ag, 6000 Frankfurt Verfahren zur synthese von oestron bzw. oestronderivaten
DD205169A1 (de) * 1982-05-26 1983-12-21 Adw Ddr Verfahren zur herstellung von 9(11)-dehydro-oestra-1,3,5(10)-trienen
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
US5395831A (en) * 1994-04-08 1995-03-07 American Home Products Corporation Treating cardiac disorders with Δ9(11)-dehydro-8-isoestrone

Also Published As

Publication number Publication date
AU2242195A (en) 1995-10-30
AU688029B2 (en) 1998-03-05
WO1995027724A1 (fr) 1995-10-19
IL113178A0 (en) 1995-06-29
ES2128051T3 (es) 1999-05-01
GR3030185T3 (en) 1999-08-31
HUT76338A (en) 1997-08-28
TW314468B (fr) 1997-09-01
CA2186486A1 (fr) 1995-10-19
US5395831A (en) 1995-03-07
DE69508068T2 (de) 1999-10-28
EP0754190A1 (fr) 1997-01-22
US5496814A (en) 1996-03-05
ATE177111T1 (de) 1999-03-15
IL113178A (en) 2000-07-26
DE69508068D1 (de) 1999-04-08
NZ283951A (en) 1998-07-28
DK0754190T3 (da) 1999-09-27
KR970702291A (ko) 1997-05-13
JPH09511748A (ja) 1997-11-25
HU9602755D0 (en) 1996-11-28
CN1149298A (zh) 1997-05-07
EP0754190B1 (fr) 1999-03-03
US5552395A (en) 1996-09-03

Similar Documents

Publication Publication Date Title
ZA952771B (en) Novel compound
AU645709B2 (en) New 2,4-thiazolidinedione compounds, process for preparing them and pharmaceutical compositions containing them
AU1280392A (en) Urea derivatives
MY115339A (en) Compositions containing micronized nebivolol
IL111861A (en) Phenyl-n-substituted azabicycloalkene derivatives and pharmaceutical compositions containing them
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
ES2017836A6 (es) Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
AU2125192A (en) New naphthylethlylureas and naphthylethylthioureas, process for the preparation thereof, and pharmaceutical compositions containing them
AU673893B2 (en) New pyridothiadiazones, processes for their preparation and the pharmaceutical compositions which contain them
HUT71798A (en) Process for preparing pharmaceutical compositions of antidepressant activity containing 2-amino-6-a-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexol)
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
HU9601511D0 (en) N-substituted azabicycloheptane derivatives used, for example, as neuroleptics
TW252979B (fr)
GR3017348T3 (en) Novel isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same.
IL112630A (en) Derivatives of (2-(ar)alkyldithioindane-2-carboxamido) tricyclic-oxobenzazepine and similar compouds useful as inhibitors of enkephalinase, their preparation and pharmaceutical compositions containing them
AU6187394A (en) New pyrrolopyrazine compounds, processes for their preparation and the pharmaceutical compositions which contain them
TW344650B (en) Fungicidal compositions and the process for the preparation thereof
ZA941196B (en) Angiopeptin cyclopeptide compounds process for the preparation thereof and pharmaceutical compositions containing them
HUT55033A (en) Process for producing aminooligohydroxy derivatives and pharmaceutical compositions comprising same
ES2049186A1 (es) Procedimiento para la preparacion de nuevos derivados de benzofuranil-imidazol.
GR3015706T3 (en) Benzylselenobenzamides of aminopyridines and picolylamines.
AU1466592A (en) Gem-diphosphonic acid nitrosocarbamoyl derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
JO1711B1 (en) Therapeutic agents